Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial

被引：0

作者：

Antoine Roquilly

Bruno Francois

Olivier Huet

Yoann Launey

Sigismond Lasocki

Emmanuel Weiss

Melanie Petrier

Yannick Hourmant

Marwan Bouras

Karim Lakhal

Cecilia Le Bel

Delphine Flattres Duchaussoy

Laia Fernández-Barat

Adrian Ceccato

Laurent Flet

Alexandra Jobert

Jeremie Poschmann

Veronique Sebille

Fanny Feuillet

Despoina Koulenti

Antoni Torres

机构：

[1] Nantes Université,ICU Department and Inserm CIC 1435 & UMR 1092

[2] CHU Nantes,Département d’anesthésie réanimation et medecine peri

[3] INSERM,operatoire, CHRU de Brest

[4] Anesthesie Réanimation,Department of Anaesthesia, Critical Care and Perioperative Medicine

[5] CIC 1413,Department of Anesthesiology and Critical Care Medicine

[6] Nantes Université,Department of Anesthesiology and Critical Care

[7] CHU Nantes,2nd Critical Care Department

[8] INSERM,Faculty of Medicine, UQ Centre for Clinical Research

[9] Center for Research in Transplantation and Translational Immunology,undefined

[10] UMR 1064,undefined

[11] University Hospital of Limoges,undefined

[12] Université de Bretagne Occidentale,undefined

[13] Univ Rennes,undefined

[14] CHU Rennes,undefined

[15] University Hospital of Angers,undefined

[16] Université Paris Cité,undefined

[17] INSERM UMR_S1149,undefined

[18] and AP-HP Nord,undefined

[19] Hôpital Beaujon,undefined

[20] CELLEX research laboratories,undefined

[21] CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias,undefined

[22] 06/06/0028),undefined

[23] Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS),undefined

[24] Servei de Pneumologia,undefined

[25] Hospital Clinic,undefined

[26] Barcelona,undefined

[27] Universitat de Barcelona,undefined

[28] CIBERES,undefined

[29] Icrea,undefined

[30] IDIBAPS,undefined

[31] Nantes Université,undefined

[32] CHU Nantes,undefined

[33] Pharmacie,undefined

[34] Nantes Université,undefined

[35] CHU Nantes,undefined

[36] DRI,undefined

[37] Département promotion,undefined

[38] cellule vigilances recherche,undefined

[39] Nantes Université,undefined

[40] CHU Nantes,undefined

[41] DRI,undefined

[42] Plateforme de Méthodologie et de Biostatistique,undefined

[43] Nantes Université,undefined

[44] Université de Tours,undefined

[45] CHU Nantes,undefined

[46] CHU Tours,undefined

[47] INSERM,undefined

[48] SPHERE U1246,undefined

[49] Attikon University Hospital,undefined

[50] The University of Queensland,undefined

来源：

Intensive Care Medicine | 2023年 / 49卷

关键词：

Intensive care; Hospital-acquired pneumonia; Interferon-gamma; Immunotherapy; Immunosuppression;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：530 / 544

页数：14

共 50 条

[41] Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial
Knight, David J. W.
Gardiner, Dale
Banks, Amanda
Snape, Susan E.
Weston, Vivienne C.
Bengmark, Stig
Girling, Keith J.
INTENSIVE CARE MEDICINE, 2009, 35 (05) : 854 - 861
[42] EFFECTS OF HUMAN GROWTH-HORMONE IN CRITICALLY ILL NONSEPTIC PATIENTS - RESULTS FROM A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
VOERMAN, BJ
VANSCHIJNDEL, RJMS
GROENEVELD, ABJ
DEBOER, H
NAUTA, JP
THIJS, LG
CRITICAL CARE MEDICINE, 1995, 23 (04) : 665 - 673
[43] Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial
David J. W. Knight
Dale Gardiner
Amanda Banks
Susan E. Snape
Vivienne C. Weston
Stig Bengmark
Keith J. Girling
Intensive Care Medicine, 2009, 35
[44] Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial
Sanyal, Arun J.
Lopez, Patricia
Lawitz, Eric J.
Lucas, Kathryn J.
Loeffler, Juergen
Kim, Won
Goh, George B. B.
Huang, Jee-Fu
Serra, Carla
Andreone, Pietro
Chen, Yi-Cheng
Hsia, Stanley H.
Ratziu, Vlad
Aizenberg, Diego
Tobita, Hiroshi
Sheikh, Aasim M.
Vierling, John M.
Kim, Yoon Jun
Hyogo, Hideyuki
Tai, Dean
Goodman, Zachary
Schaefer, Felicity
Carbarns, Ian R. I.
Lamle, Sophie
Martic, Miljen
Naoumov, Nikolai V.
Brass, Clifford A.
NATURE MEDICINE, 2023, 29 (02) : 392 - +
[45] Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial
Arun J. Sanyal
Patricia Lopez
Eric J. Lawitz
Kathryn J. Lucas
Juergen Loeffler
Won Kim
George B. B. Goh
Jee-Fu Huang
Carla Serra
Pietro Andreone
Yi-Cheng Chen
Stanley H. Hsia
Vlad Ratziu
Diego Aizenberg
Hiroshi Tobita
Aasim M. Sheikh
John M. Vierling
Yoon Jun Kim
Hideyuki Hyogo
Dean Tai
Zachary Goodman
Felicity Schaefer
Ian R. I. Carbarns
Sophie Lamle
Miljen Martic
Nikolai V. Naoumov
Clifford A. Brass
Nature Medicine, 2023, 29 : 392 - 400
[46] A PHASE 1B/2A RANDOMISED, PLACEBO-CONTROLLED CLINICAL TRIAL WITH SNF472 IN HAEMODIALYSIS PATIENTS
Salcedo, Carolina
Perello, Joan
Ojeda, Raquel
Joubert, Pieter H.
Arias, Marta
Canals, Ana Z.
Ferrer, Miguel D.
Torregrosa, Vicens
Campistol, Josep M.
Maduell, Francesc
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 13 - 13
[47] Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial
Meijvis, Sabine C. A.
Hardeman, Hans
Remmelts, Hilde H. F.
Heijligenberg, Rik
Rijkers, Ger T.
van Velzen-Blad, Heleen
Voorn, G. Paul
van de Garde, Ewoudt M. W.
Endeman, Henrik
Grutters, Jan C.
Bos, Willem Jan W.
Biesma, Douwe H.
LANCET, 2011, 377 (9782): : 2023 - 2030
[48] HRCT diagnosis of IPF and relationship between HRCT characteristics and histology and clinical findings in patients in a phase 3, randomized, double-blind, palcebo-controlled trial fo interferon gamma-1B (IFN-gamma 1B)
Lynch, D
Godwin, JD
Webb, WR
Brown, KK
Bradford, WZ
Noble, PW
Raghu, G
Schwartz, DA
Starko, KM
CHEST, 2004, 126 (04) : 773S - 773S
[49] Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
V. Ratziu
L. de Guevara
R. Safadi
F. Poordad
F. Fuster
J. Flores-Figueroa
M. Arrese
Anna L. Fracanzani
D. Ben Bashat
K. Lackner
T. Gorfine
S. Kadosh
R. Oren
M. Halperin
L. Hayardeny
R. Loomba
S. Friedman
Arun J. Sanyal
Nature Medicine, 2021, 27 : 1825 - 1835
[50] Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial
Timsit, Jean-Francois
Huntington, Jennifer A.
Wunderink, Richard G.
Shime, Nobuaki
Kollef, Marin H.
Kivistik, Ulo
Novacek, Martin
Rea-Neto, Alvaro
Martin-Loeches, Ignacio
Yu, Brian
Jensen, Erin H.
Butterton, Joan R.
Wolf, Dominik J.
Rhee, Elizabeth G.
Bruno, Christopher J.
CRITICAL CARE, 2021, 25 (01)

← 1 2 3 4 5 →